ARCANO advises Schülke Group, an EQT portfolio company, on the acquisition of Vesismin Health

ARCANO has acted as exclusive financial Advisor to Schülke Group, an EQT portfolio company, global leader in infection prevention solutions, on the acquisition of Vesismin Health, a Spanish company specializing in infection control.

This transaction will allow Schülke to expand its geographic presence in Southern Europe as well as expand its product portfolio.

Vesismin Health
Prevention of infection deseases

Schülke Mayr GmbH is a world leader in infection prevention to the healthcare industry with more than 130 years of experience. Schülke offers comprehensive concepts for infection prevention in the professional healthcare, consumer and pharmaceutical markets. Committed to the mission of protecting lives around the world, it actively contributes to the safety and protection of human health in the strategic business areas of Healthcare, Over the Counter (OTC) and Industrial Hygiene. Schülke has over 1 100 employees, more than 20 subsidiaries and 3 production centers in Germany (Schülke), France (Bioxal) and Brazil (Vic Pharma).
Customers in more than 80 countries around the world trust their products every day.

EQT is one of the leading private equity firms globally with more than 77 bn under management through 19 active funds. EQT funds have over 250 portfolio companies in Europe, Asia and the United States with total sales of more than 27 bn and c 159 000 employees. EQT seeks to help its portfolio companies achieve sustainable growth, operational excellence and leadership in their respective markets. With offices in 23 countries in Europe,  Asia Pacific and America, and over 1 500 employees.

Vesismin Health headquartered in the Barcelona Science Park, was founded in 2004 in Barcelona by the entrepreneur Víctor Vallés Since then, the main objective of the company has been to collaborate with hospitals  and health centers on the fight against infectious diseases, providing effective and innovative disinfection solutions Vesismin is a benchmark in hospital disinfection at the national level. The company has presence in more than 400 hospitals in Spain and is expanding to other markets, such as pharmaceuticals and veterinary.